All Penn Allergy & Immunology Faculty
Olajumoke Fadugba
Associate Professor of Clinical Medicine (Pulmonary, Allergy and Critical Care)
Department: Medicine
Contact information
3737 Market Street
Philadelphia, PA 19104
Philadelphia, PA 19104
Office: 2156622775
Fax: 2156155055
Fax: 2156155055
Publications
Education:
Year 1 (Biotechnology)
Imperial College London, 2002.
BSc (Major in Biochemistry, Minor in Medical Humanities )
University of Delaware, 2005.
MD (Medicine)
Vanderbilt University School of Medicine , 2009.
Year 1 (Biotechnology)
Imperial College London, 2002.
BSc (Major in Biochemistry, Minor in Medical Humanities )
University of Delaware, 2005.
MD (Medicine)
Vanderbilt University School of Medicine , 2009.
Post-Graduate Training
Intern, Internal Medicine, Washington University School of Medicine, 2009-2010.
Resident, Internal Medicine, Washington University School of Medicine, 2010-2012.
Fellow, Allergy & Immunology, Vanderbilt University School of Medicine, 2012-2014.
Course in Clinical Trials, Vanderbilt University School of Medicine , 2013-2013.
Intern, Internal Medicine, Washington University School of Medicine, 2009-2010.
Resident, Internal Medicine, Washington University School of Medicine, 2010-2012.
Fellow, Allergy & Immunology, Vanderbilt University School of Medicine, 2012-2014.
Course in Clinical Trials, Vanderbilt University School of Medicine , 2013-2013.
Certifications
American Board of Internal Medicine (certified 2012, recertified 2022), 2012.
American Board of Allergy and Immunology, 2014.
Permanent linkAmerican Board of Internal Medicine (certified 2012, recertified 2022), 2012.
American Board of Allergy and Immunology, 2014.
Selected Publications
Olajumoke Fadugba: Code Red Air Quality (interview regarding impact of poor air quality caused by Canadian wild fires on human health). WHYY Radio Station June 2023.Olajumoke Fadugba (interview/publication by Sophia Schmidt): How wildfire smoke affects your health, and how to protect yourself. WHYY Radio Station June 2023.
Fernandez E, Chandler W, Long PR, Palmer ML, Fadugba O.: Dupilumab-Associated Sweet Syndrome. Cutis 111(6): E7-E9, June 2023.
Patel VM, Chu B, Hamilton KW, Bellamy C, Harker C, Bryer JS, Shields B, Hirsh RL, Fadugba OO, Micheletti RG.: Penicillin allergy evaluation in hospitalized patients with hematologic malignancy. Antimicrob Steward Healthc Epidemiol. 3(2): e92, May 2023.
Perspective from Olajumoke Fadugba (article by Anthony DeFino): Expert Perspective on published article: "Prior high-risk penicillin reactions should not prevent provocation challenges in children" Healio March 2023.
Daniel Herman, Ranran Zhang, Sayeda Humaira, Yachana Pancha1, Marvi Rizwan, Olajumoke O. Fadugba, Daniel Shaheen, Elizabeth Hexner: Development of scalable, electronic health record (EHR)-based screening for undiagnosed systemic mastocytosis: PREDICT-SM. American Academy of Allergy, Asthma and Immunology Conference Feb 2023.
Dharia T, Lynch DM, Castells MC, Fadugba OO: Endogenous progesterone dermatitis: Successful suppression and desensitization. Ann Allergy Asthma Immunol Dec 2022.
Csomos K, Ujhazi B, Blazso P, Herrera JL, Tipton CM, Kawai T, Gordon S, Ellison M, Wu K, Stowell M, Haynes L, Cruz R, Zakota B, Nguyen J, Altrich M, Geier CB, Sharapova S, Dasso JF, Leiding JW, Smith G, Al-Herz W, de Barros Dorna M, Fadugba O, Fronkova E, Kanderova V, Svaton M, Henrickson SE, Hernandez JD, Kuijpers T, Kandilarova SM, Naumova E, Milota T, Sediva A, Moshous D, Neven B, Saco T, Sargur R, Savic S, Sleasman J, Sunkersett G, Ward BR, Komatsu M, Pittaluga S, Kumanovics A, Butte MJ, Cancro MP, Pillai S, Meffre E, Notarangelo LD, Walter JE: Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet+ B cells. Nat Immunol Aug 2022.
Patel V, Gleeson PK, Delaney K, Ralston SJ, Feldman S, Fadugba O: Safety and outcomes of penicillin allergy evaluation in pregnant women. Ann Allergy Asthma Immunol May 2022 2022.
Bediako H, Dutcher L, Rao A, Sigafus K, Harker C, Hamilton KW, Fadugba O: Impact of an inpatient nurse-initiated penicillin allergy delabeling questionnaire. Antimicrob Steward Healthc Epidemiol May 2022.
